Abstract
Sjogren’s syndrome (SS) is a chronic autoimmune disorder affecting mainly middle-aged women. It is characterized by lymphocytic infiltration and destruction of the exocrine glands (mainly the salivary and lacrimal glands), resulting in dry mouth and eyes. Symptoms of SS are chronic and sometimes devastating, compromising the quality of life at a major extent. Despite its autoimmune nature, evidence for the use of immunosuppressive agents, which are the mainstay of therapy of diseases of autoimmune origin, is limited. Keratoconjunctivitis sicca (KCS), the main ocular manifestation of SS, is managed with tear substitutes, as well as local and systemic stimulators of tear secretion and supportive surgical procedures. Management of oral manifestations includes intense oral hygiene, prevention and treatment of oral infections, use of saliva substitutes, and local and systematic stimulation of salivary secretion. Cholinergic agents, such as pilocarpine and cevimeline are the cornerstone of current therapy in SS. Corticosteroids, cyclophoshamide, and nucleoside analogues are reserved for severe extraglandular manifestations of SS. The role of anti-B-cell therapy is a promising option for glandular and extraglandular manifestations of the disease, as well as for the management of SS-associated lymphoma.
Similar content being viewed by others
References
Kassan SS, Moutsopoulos HM (2004) Arch Intern Med 164:1275–1284
Skopouli FN, Dafni U, Ioannidis JP, Moutsopoulos HM (2000) Semin Arthritis Rheum 29:296–304
Samarkos M, Moutsopoulos HM (2005) Curr Allergy Asthma Rep 5:327–332
Tauber J et al (2004) Cornea 23:784–792
Porter SR, Scully C, Hegarty AM (2004) Oral Surg Oral Med Oral Pathol Oral Radiol Endod 97:28–46
Boutsi EA, Paikos S, Dafni UG, Moutsopoulos HM, Skopouli FN (2000) J Clin Periodontol 27:231–235
Pedersen AM, Bardow A, Nauntofte B (2005) BMC Clin Pathol 5:4
Ellepola AN, Samaranayake LP (2000) Crit Rev Oral Biol Med 11:172–198
Moutsopoulos NM, Moutsopoulos HM (2001) Springer Semin Immunopathol 23:131–145
Johnstone PA, Niemtzow RC, Riffenburgh RH (2002) Cancer 94:1151–1156
Haila S, Koskinen A, Tenovuo J (2005) Homeopathy 94:175–181
Frost PM, Shirlaw PJ, Challacombe SJ, Fernandes-Naglik L, Walter JD, Ide M (2006) Oral Dis 12:57–62
Vivino FB, Al-Hashimi I, Khan Z et al (1999) Arch Intern Med 159:174–181
Tsifetaki N, Kitsos G, Paschides CA et al (2003) Ann Rheum Dis 62:1204–1207
Porter SR, Scully C, Hegarty AM (2004) Oral Surg Oral Med Oral Pathol Oral Radiol Endod 97:28–46
Fife RS, Chase WF, Dore RK et al (2002), Arch Intern Med 162:1293–1300
Petrone D, Condemi JJ, Fife R et al (2002) Arthritis Rheum 46:748–754
Ono M, Takamura E, Shinozaki K et al (2004) Am J Ophthalmol 138:6–17
Takagi Y, Kimura Y, Nakamura T (2004) Ann Rheum Dis 63:749
Valtysdottir ST, Wide L, Hallgren R (2001) J Rheumatol 28:1259–1265
Pillemer SR, Brennan MT, Sankar V et al (2004) Arthritis Rheum 51:601–604
Skopouli FN, Fox PC, Galanopoulou V et al (1991) J Rheumatol 18:210–214
Drosos AA, Skopouli FN, Costopoulos JS et al (1986) Ann Rheum Dis 45:732–735
Boumba D, Skopouli FN, Moutsopoulos HM (1995) Br J Rheumatol 34:326–333
Skopouli FN, Jagiello P, Tsifetaki N et al (1996) Clin Exp Rheumatol 14:555–558
Price EJ, Rigby SP, Clancy U et al (1998) J Rheumatol 25:896–899
Zandbelt MM, van den Hoogen FH, de Wilde PC et al (2001) Ann Rheum Dis 60:511–513
Fox PC, Datiles M, Atkinson JC et al (1993) Clin Exp Rheumatol 11:149–156
Linardaki G, Moutsopoulos HM (1997) Cleve Clin J Med 64:523–526
Tishler M, Yaron I, Shirazi I et al (1999) Arch Oral Biol 44:305–308
Manoussakis MN, Moutsopoulos HM (1996) Lupus 5(Suppl 1):S28–S30
ter Borg EJ, Haanen HC, Haas FJ et al (2002) Neth J Med 60:402–406
Pillemer SR, Leakan RA, Sankar V et al (2004) Arthritis Rheum 51:505–506
Moutsopoulos NM, Angelov N, Sankar V, Leakan RA, Pillemer S, Wahl SM (2006) Ann Rheum Dis 65:112–114
Steinfeld SD, Demols P, Van Vooren JP et al (1999) Rheumatology (Oxford) 38:814–817
Belafsky PC, Postma GN (2003) Curr Rheumatol Rep 5:297–303
Bennet R (1998) In: Wallace D (ed) The New Sjogren’s Syndrome Handbook, pp 118–123
Skopouli FN et al R (1990) J Rheumatol 17:618–620
Garcia-Carrasco M et al (2002) J Rheumatol 29:726–730
Goules A et al (2000) Medicine (Baltimore) 79:241–249
Linardaki G, Moutsopoulos HM (1997) Clevel Clin J Med 64:523–526
Moutsopoulos HM et al (1978) Am J Med 64:955–960
Matsumoto T et al (2005) Pathol Int 55:70–76
Skopouli FN, Barbatis C, Moutsopoulos HM (1994) Br J Rheumatol 33:745–748
Papiris SA et al (1999) Ann Rheum Dis 58:61–64
Taouli B, Brauner MW, Mourey I, Lemouchi D, Grenier PA (2002) Eur Radiol 12:1504–1511
Soliotis FC, Mavragani CP, Moutsopoulos HM (2004) Ann Rheum Dis 63:616–620
de Seze J, Delalande S, Fauchais AL, Hachulla E, Stojkovic T, Ferriby D, Hatron PY, Vermersch P (2006) J Rheumatol 33:709–711
Font J et al (2003) J Rheumatol 30:1552–1557
Levy Y et al (2005) Ann N Y Acad Sci 1051:779–786
Mochizuki H et al (2002) Intern Med 41:142–146
Takahashi Y, Takata T, Hoshino M, Sakurai M, Kanazawa I (2003) Neurology 60:503–505
Steinfeld SD, Demols P, Appelboom T (2002) Arthritis Rheum 46:3301–3303
Skopouli FN, Papanikolaou S, Malamou-Mitsi V, Papanikolaou N, Moutsopoulos HM (1994) Ann Rheum Dis 53:569–573
Haga HJ, Gjesdal CG, Irgens LM, Ostensen M (2005) Scand J Rheumatol 34:45–48
Ramos-Casals M et al (2004) Medicine (Baltimore) 83:96–106
Somer BG, Tsai DE, Downs L, Weinstein B, Schuster SJ (2003) Arthritis Rheum 49:394–398
Gottenberg JE et al (2005) Ann Rheum Dis 64:913–920
Pijpe J et al (2005) Ann Rheum Dis 64:958–960
Voulgarelis M, Giannouli S, Anagnostou D, Tzioufas AG (2004) Rheumatology (Oxford) 43:1050–1053
Voulgarelis M, Giannouli S, Tzioufas AG, Moutsopoulos HM (2005) Ann Rheum Dis 65:1033–1037
Ramos-Casals M, Lopez-Guillermo A, Brito-Zeron P, Cervera R, Font J (2004) Lupus 13:969–971
Voulgarelis M, Petroutsos G, Moutsopoulos HM, Skopouli FN (2002) Arthritis Rheum 46:2248–2249
Acknowledgment
We would like to thank Dr. N. M. Moutsopoulos, DDS for helpful discussions in the management of oral manifestations of Sjogren’s syndrome.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mavragani, C.P., Moutsopoulos, H.M. Conventional Therapy of Sjogren’s Syndrome. Clinic Rev Allerg Immunol 32, 284–291 (2007). https://doi.org/10.1007/s12016-007-8008-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12016-007-8008-3